Agenus Inc., a scientific-phase biotechnology company, discovers and develops therapies to activate the body's immune procedure against most cancers and infections in the United States and internationally. It offers Retrocyte Display screen, an antibody expression platform to the identification of totally human and humanized monoclonal antibodies;